IMARC Group has recently released a new research study “Pressure Ulcers Treatment Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
What are the growth prospects of the Pressure Ulcers Treatment Industry?
The global Pressure Ulcers Treatment Market size reached US$ 4.75 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 6.58 Billion by 2027, exhibiting a growth rate (CAGR) of 5.40% during 2022-2027.
Request For Sample Report: https://www.imarcgroup.com/pressure-ulcers-treatment-market/requestsample
What is a Pressure Ulcers Treatment Market ?
Pressure ulcers, also known as bedsores, are underlying tissue injuries caused by prolonged pressure and shearing forces on the skin. They usually affect the buttocks, tailbone, back, heels, elbow, shoulder, and ankles. They can be cured by preventive measures and medications that help prevent and cure deep craters with exposed muscle and bone.
The treatment involves reducing pressure on the affected skin, removing necrotic tissue, controlling pain, and maintaining a moist environment for wound healing.
Over the years, there has been growing awareness among individuals about the early identification and treatment of bedsores to minimize the risk of complications and prevent cancer.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
What are the major market drivers in the Pressure Ulcers Treatment Market:
The market is primarily driven by the rising geriatric population that is more susceptible to developing pressure ulcers due to skin fragility.
In addition, the growing prevalence of obesity and chronic medical diseases is escalating the incidences of pressure ulcers, thus contributing to market growth.
Besides this, the leading market players are focusing on developing novel wound care products. This, coupled with the rising awareness among individuals about the early diagnosis of ulcers and the available treatment options, is positively influencing the market growth.
Furthermore, the increasing numbers of hospitals, clinics, pharmacies, and drug stores across the globe and various technological advancements in the healthcare industry are also creating a favorable market outlook across the globe.
|Pressure Ulcers Treatment Market Report Scope|
|Market size value in 2021||US$ 4.75 Billion|
|Market forecast in 2027||US$ 6.58 Billion|
|Growth Rate||CAGR of 5.40% from 2022 to 2027|
|Base year for estimation||2021|
|Report coverage||Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends|
|Segments covered||Ulcer Type, Product Type And End User|
|Regional scope||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Key companies profiled||3M Company, Arjo AB, B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG), Cardinal Health Inc., Coloplast A/S, Hill-Rom Holdings Inc. (Baxter International Inc.), Invacare Corporation, Mölnlycke Health Care AB, Smith & Nephew plc, Span America (UTi Worldwide Inc.), Stiegelmeyer GmbH & Co. KG and Stryker Corporation.|
|Market Dynamics||Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,|
|Customization purview||If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.|
Click here to view detailed information with table of content: https://www.imarcgroup.com/pressure-ulcers-treatment-market
The report has been segmented the market into following categories:
Breakup by Type:
- Artificial Saliva/Saliva Substitutes
- Salivary Stimulants
Breakup by Drug Type:
Breakup by Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
List of Major Key Players:
3M Company, Arjo AB, B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG), Cardinal Health Inc., Coloplast A/S, Hill-Rom Holdings Inc. (Baxter International Inc.), Invacare Corporation, Mölnlycke Health Care AB, Smith & Nephew plc, Span America (UTi Worldwide Inc.), Stiegelmeyer GmbH & Co. KG and Stryker Corporation.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800